Related Experiment Video
Updated: Aug 6, 2026

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
Empiric therapy for pneumonia in the surgical intensive care unit
1Department of Surgery, University of Tennessee, Memphis, Tennessee, USA
Abstract:
Empiri c therapy of ventilator-associated pneumonia (VAP) in surgical patients should be based on intensive care unit (ICU)-specific surveillance data, because microbial flora patterns vary widely between geographic regions as well as within hospitals. Surgical ICUs have higher VAP rates than other units. Data from the National Nosocomial Infection Surveillance (NNIS) System report Pseudomonas aeruginosa and Staphylococcus aureus to be the most frequent isolates (each 17.4%). Data from the NNIS documents high resistance patterns in ICUs compared with hospitals at large, as well as unit-specific patterns. VAP risk factors for surgical patients include thoracoabdominal surgery, altered level of consciousness, advanced age, diabetes mellitus, malnutrition, chronic obstructive pulmonary disease, and prior antibiotic administration. Promising prevention strategies include restricting ventilator circuit changes, in-line heat moisture exchange filters, semi-recumbant positioning, and continuous subglottic aspiration. Pharmacodynamics should be considered when choosing antibiotic regimens. Postantibiotic effect and time-dependent versus concentration-dependent killing should be studied in clinical trials. Current guidelines for choosing regimens have been well developed by the American Thoracic Society.
Insights
Empirical therapy for ventilator-associated pneumonia (VAP) in surgical patients requires ICU-specific data due to varying microbial patterns. Pseudomonas aeruginosa and Staphylococcus aureus are common, with high resistance noted in intensive care units (ICUs).
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Surgical Infections
Background:
- Ventilator-associated pneumonia (VAP) presents unique challenges in surgical intensive care units (ICUs), often exhibiting higher incidence rates compared to other hospital units.
- Microbial flora patterns and antibiotic resistance vary significantly across different geographic locations and even within individual hospitals, necessitating localized surveillance data.
- Pseudomonas aeruginosa and Staphylococcus aureus are identified as the most prevalent pathogens causing VAP, according to data from the National Nosocomial Infection Surveillance (NNIS) System.
Purpose of the Study:
- To emphasize the critical need for ICU-specific surveillance data in guiding empirical VAP therapy for surgical patients.
- To highlight the common pathogens and resistance patterns observed in surgical ICUs.
- To review established risk factors and emerging prevention strategies for VAP in this patient population.
Main Methods:
- Analysis of data from the National Nosocomial Infection Surveillance (NNIS) System to identify common microbial isolates and resistance patterns in ICUs.
- Review of established risk factors associated with VAP development in surgical patients.
- Evaluation of current and emerging VAP prevention strategies.
Main Results:
- Pseudomonas aeruginosa and Staphylococcus aureus are the most frequent isolates in VAP cases, each accounting for 17.4% of infections.
- Intensive care units (ICUs) demonstrate higher rates of antibiotic resistance compared to general hospital settings, with distinct unit-specific patterns.
- Identified VAP risk factors in surgical patients include thoracoabdominal surgery, altered consciousness, advanced age, comorbidities like diabetes mellitus and COPD, malnutrition, and prior antibiotic use.
Conclusions:
- Empirical VAP treatment in surgical patients must be informed by local ICU surveillance data due to geographic and hospital-specific microbial variations.
- Pharmacodynamic principles, including post-antibiotic effects and concentration-dependent killing, should guide antibiotic regimen selection, adhering to established guidelines such as those from the American Thoracic Society.
- Promising prevention strategies like continuous subglottic aspiration and semi-recumbent positioning warrant further investigation and implementation.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
03:22Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia I: Introduction